Making Sense of the Numbers

October 2010
Pharmaceutical Representative;Oct2010, Vol. 40 Issue 10, p11
The article offers information on the Pharma Industry Audit, which examines the financial performances of 24 pharmaceutical companies in the U.S. regarding their enterprise value and measurable gains.


Related Articles

  • Drug store suppliers turn in anemic quarterly results.  // Chain Drug Review;6/25/2012, Vol. 34 Issue 11, p38 

    The article reports that majority of drug store suppliers in the U.S. posted an unfavorable financial results as of the first quarter of 2012 wherein its net margin declined to 16.3% from 17.2%. INSET: Supplier Sales and Earnings: First Quarter 2012.

  • U.S. operations generate lion's share of sales, operating profit.  // Chain Drug Review;4/18/2016, Vol. 38 Issue 7, p17 

    The article reports on the financial performance of the U.S. retail pharmacy business in the second quarter of fiscal 2016 with focus on their operating profits.

  • UNITED STATES PHARMACEUTICALS.  // Acquisdata Industry SnapShot: United States - Pharmaceuticals;8/28/2014, Issue 1819, p1 

    The report presents an update business reports regarding the developments of pharmaceutical industries in the U.S. as of August 28, 2014 which includes latest market research on medicines, overview on leading pharmaceutical industries and financial performance of drugstores.

  • Quintiles Reports Second Quarter Results.  // Drug Discovery & Development;Jul/Aug2013, Vol. 16 Issue 4, p16 

    The article reports on the financial performance of biopharmaceutical services provider Quintiles Transnatioal Holdings Inc. in the U.S. for the second quarter of 2013.

  • Analyst Coverage Starts On Global Blood, Post IPO. BRIAN DEAGON // Investors Business Daily;9/8/2015, p00 

    The article reports on the financial performance of American pharmaceutical company Global Blood Therapeutics Inc. as of August 2015, highlighting its coverage rating and trading.

  • JOHNSON & JOHNSON.  // Acquisdata Company SnapShot: Johnson & Johnson;2/8/2016, Issue 630, p1 

    A company profile report for U.S. pharmaceutical and health care products company Johnson & Johnson is presented from publisher Acquisdata Pty. Ltd., with topics including its 2015 fourth-quarter and full-year financial results, medical devices businesses, and the U.S. biopharmaceutical industry.

  • 2012 U.S. Pharmaceutical Preparation Mfg. Industry Report.  // Biomedical Market Newsletter;10/31/2011, Vol. 21, p216 

    The article discusses the publication of the Pharmaceutical Preparation Manufacturing Industry-Industry & Market report in the U.S. The report covers timely and accurate industry statistics, forecasts, and demographics. The report also features financial ratios, number of firms, and payroll...

  • Adjusted net soars 140% at Diplomat.  // Chain Drug Review;4/18/2016, Vol. 38 Issue 7, p20 

    The article reports on the growth of the adjusted net income of more than 140% at Diplomat Pharmacy, the largest independent specialty pharmacy in the U.S., in fiscal 2015 as revenue increased better than 50% due to acquisitions.

  • WALL ST./FINANCE.  // MondayMorning;11/16/2009, Vol. 17 Issue 44, p3 

    The article reports on the financial performance of biopharmaceutical industry in the U.S. Trius Therapeutics Inc. has obtained about 86.25 million dollars common stock through the assistance of Credit Suisse Securities LLC in California. Alimera Sciences Inc. has earned about 80 million dollars...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics